Related Experiment Video
Updated: Aug 11, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Catheter ablation improved ejection fraction in persistent AF patients: a DECAAF-II sub analysis
Mario Mekhael1, Botao Shan1, Charbel Noujaim1
1Tulane Research and Innovation for Arrhythmia Discoveries- TRIAD Center, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA.
Insights
Catheter ablation for atrial fibrillation (AF) shows similar recurrence and burden in congestive heart failure (CHF) patients compared to non-CHF. Patients with heart failure with reduced ejection fraction (HFrEF) experienced the greatest LVEF improvement post-ablation.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Atrial fibrillation (AF) is a common arrhythmia, often co-occurring with congestive heart failure (CHF).
- Catheter ablation (CA) is a treatment option for AF, but its efficacy in CHF patients requires further investigation.
- Understanding AF recurrence and impact on left ventricular ejection fraction (LVEF) in different CHF subcategories is crucial.
Purpose of the Study:
- To compare post-ablation AF recurrence and burden between CHF and non-CHF patients.
- To assess changes in LVEF across various CHF subcategories after CA.
- To evaluate the relationship between atrial fibrosis and LVEF improvement post-ablation.
Main Methods:
- Retrospective analysis of the DECAFF-II trial population.
- Comparison of AF recurrence and burden between CHF and non-CHF groups, including CHF subgroups.
- Quantification and comparison of LVEF changes across CHF groups and fibrosis stages.
Main Results:
- No significant differences in AF recurrence or burden were observed between CHF and non-CHF patients post-CA.
- Patients with heart failure with reduced ejection fraction (HFrEF) showed the most significant LVEF improvement (16.66%) after CA.
- LVEF improvement was independent of the stage of atrial fibrosis (P = 0.115).
Conclusions:
- Catheter ablation outcomes for AF are comparable between CHF and non-CHF patients, irrespective of CHF type.
- HFrEF patients benefit most from CA in terms of LVEF improvement.
- Ventricular function enhancement post-ablation appears unrelated to atrial fibrosis in persistent AF.
Aims:
The aim of our study was to assess differences in post-ablation atrial fibrillation (AF) recurrence and burden and to quantify the change in LVEF across different congestive heart failure (CHF) subcategories of the DECAAF-II population.
Methods And Results:
Differences in the primary outcome of AF recurrence between CHF and non-CHF groups was calculated. The same analysis was performed for the three subgroups of CHF and the non-CHF group. Differences in AF burden after the 3-month blanking period between CHF and non-CHF groups was calculated. Improvement in LVEF was calculated and compared across the three CHF groups. Improvement was also calculated across different fibrosis stages. There was no significant differences in AF recurrence and AF burden after catheter ablation between CHF and non-CHF patients and between different CHF subcategories. Patients with heart failure with reduced ejection fraction (HFrEF) experienced the greatest improvement in EF following catheter ablation (CA, 16.66% ± 11.98, P < 0.001) compared to heart failure with moderately reduced LVEF, and heart failure with preserved EF (10.74% ± 8.34 and 2.00 ± 8.34 respectively, P-value < 0.001). Moreover, improvement in LVEF was independent of the four stages of atrial fibrosis (7.71 vs. 9.53 vs. 5.72 vs. 15.88, from Stage I to Stage IV respectively, P = 0.115).
Conclusion:
Atrial fibrillation burden and recurrence after CA is similar between non-CHF and CHF patients, independent of the type of CHF. Of all CHF groups, those with HFrEF had the largest improvement in LVEF after CA. Moreover, the improvement in ventricular function seems to be independent of atrial fibrosis in patients with persistent AF.
More Related Videos
10:46Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
08:00Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
Published on: June 15, 2015
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiac Catheterization III: Left Heart Catheterization
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Cardiopulmonary Resuscitation III: AED Use